Per Bjorkman

Per Bjorkman has a strong background in executive leadership and board positions. Per is currently the Chief Commercial Officer at SHL Healthcare AB, where they oversee the development and manufacturing of MedTech solutions. Prior to that, they served as the Managing Director of SHL Technologies & SHL Ventures at SHL Medical, where they were responsible for designing and manufacturing drug delivery systems and other medical products. Per Bjorkman has also held executive board positions at Solace Holdings, Clover Leaf Capital Corp., and Offerator. Additionally, they have served as the Chairman of the Board at Enexis AB, a venture capital and private equity investment firm focused on plant-based medical and industrial applications. Per has also served as a Senior Advisor at Quio, a connected therapeutics company, and as the Chairman of Innovation Zed, a company focused on connected healthcare solutions. Furthermore, they have served as a Board Director at Ramundberget Alpina AB and the Royal Swedish Automobile Club.

Per Bjorkman has a diverse education history. In 1983, they attended Lundsbergsskola for an unspecified program. Per then pursued a Bachelor of Business Administration (BBA) degree from EU Business School from 1990 to 1992. In 2011 and 2012, they participated in two executive programs at INSEAD, namely "Executive Program - Strategy Execution" and "Executive Program - Leading for results" respectively. No specific degree or field of study is mentioned for the executive programs.